Edwards Lifesciences Corporation
Cash Flow History
| Fiscal Year | Operating Cash Flow | Free Cash Flow | CapEx | Share-Based Compensation |
|---|---|---|---|---|
| FY2008 | $153.2M | $102.6M | $50.6M | $28.7M |
| FY2009 | $165.3M | $101.3M | $64.0M | $28.3M |
| FY2010 | $251.4M | $189.6M | $61.8M | $29.3M |
| FY2011 | $308.2M | $231.6M | $76.6M | $35.0M |
| FY2012 | $362.1M | $253.1M | $109.0M | $42.1M |
| FY2013 | $472.7M | $363.7M | $109.0M | $47.4M |
| FY2014 | $1.02B | $939.4M | $82.9M | $48.3M |
| FY2015 | $549.7M | $447.0M | $102.7M | $49.9M |
| FY2016 | $704.4M | $528.3M | $176.1M | $56.9M |
| FY2017 | $1.00B | $832.6M | $168.1M | $61.6M |
| FY2018 | $926.7M | $688.0M | $238.7M | $71.0M |
| FY2019 | $1.18B | $928.5M | $254.4M | $81.3M |
| FY2020 | $1.05B | $647.3M | $407.0M | $92.6M |
| FY2021 | $1.73B | $1.41B | $325.8M | $109.3M |
| FY2022 | $1.22B | $973.6M | $244.6M | $126.8M |
| FY2023 | $895.8M | $642.8M | $253.0M | $139.4M |
| FY2024 | $542.3M | $289.9M | $252.4M | $162.3M |
| FY2025 | $1.60B | $1.34B | $260.2M | $158.1M |